查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2042700

全球醫療聯邦學習市場：按組件、部署模式、學習架構、協作模型、資料模態、應用和地區分類－市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Federated Learning in Healthcare Market: By Component, Deployment Mode, Learning Architecture, Collaboration Model, Data Modality, Application, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 280 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球醫療聯邦學習市場正經歷著快速且變革性的成長，這主要得益於醫療保健產業對安全且注重隱私保護的人工智慧技術日益成長的需求。預計到2035年，該市場規模將從2025年的約3,512萬美元成長至約1.583億美元，在2026年至2035年的預測期內，複合年成長率（CAGR）將達到16.25%。這一顯著的成長軌跡反映了分散式機器學習框架的日益普及，這些框架使醫療機構能夠在不直接洩露敏感患者資訊的情況下，協作利用大規模醫療資料集。

市場擴張的主要驅動力之一是對協作式醫療人工智慧系統日益成長的需求，這些系統需要在不損害患者隱私或資料安全的前提下有效運作。傳統的集中式資料共用模式通常要求醫療機構將高度敏感的病患記錄傳輸到統一的儲存庫，這增加了資料外洩、未授權存取和違反監管規定的風險。聯邦學習透過僅交換加密的模型更新資訊而非原始數據，並在每個機構的基礎設施內本地訓練人工智慧模型，從而克服了這些挑戰。

顯著的市場趨勢

目前，醫療聯邦學習市場的競爭格局主要由幾家大型科技公司和醫療機構主導，它們在商業醫療人工智慧領域佔主導地位。這些公司透過對分散式運算基礎設施、先進機器學習技術、安全醫療分析平台的大規模投資，以及與醫院、製藥公司和研究機構的策略夥伴關係，來維持其領先地位。

憑藉其無與倫比的運算硬體基礎設施和高度先進的專有協作式人工智慧軟體框架，NVIDIA 正在崛起成為全球醫療聯邦學習生態系統中最具主導地位的參與者之一。 Owkin 透過與大型製藥企業、生技公司和臨床研究機構建立廣泛的夥伴關係，在醫療聯邦學習市場佔了重要地位。

西門子醫療憑藉其遍布全球的診斷影像和先進醫療技術生態系統，在醫療聯邦學習市場中保持著舉足輕重的地位。通用電氣醫療則利用其全球醫院硬體和醫療技術平台網路，持續拓展其在分散式醫療智慧領域的影響力。

FedML透過提供高度專業化、去中心化的機器學習工具，獲得了可觀的市場價值。這些工具專為保護敏感的醫療保健參數和最佳化聯邦訓練環境而設計。這些領先公司透過積極制定基礎性的互通性標準和去中心化的人工智慧框架，確立了其在市場上的主導地位，這些標準和框架目前已被醫療保健行業廣泛應用。

主要成長要素

在蓬勃發展的去中心化協作診斷產業，消費者團體和醫療保健相關人員對即時、可靠且注重隱私的醫療資料管理解決方案的需求日益成長。隨著醫療系統將病患病歷、影像、基因組資訊和臨床研究資料集數位化，人們對未授權存取、資料濫用和網路安全威脅的擔憂也顯著加劇。尤其是在全球範圍內發生的一系列大規模醫療資料外洩事件，導致高度敏感的醫療資訊洩露，這提高了患者對集中式醫療資料庫相關風險的認知。這種認知的提高正在加速對聯邦學習技術的需求，這些技術優先考慮去中心化資料處理和病患隱私，同時支援先進的人工智慧主導醫療創新。

新機會的趨勢

隨著多個國家和地區日益嚴格的資料在地化法規的實施，診所、醫院和醫學研究機構被迫採用完全去中心化的人工智慧訓練模式。世界各國政府和監管機構持續加強跨境醫療資料傳輸的限制，以保護病患隱私和國家資料主權。這種不斷演變的法規結構使得跨國醫療機構集中聚合醫療數據變得越來越困難且成本高昂。因此，聯邦學習應運而生，成為一種極具吸引力的替代方案，使機構能夠在遵守本地數據本地化要求的同時，參與全球人工智慧合作舉措。這種向去中心化醫療分析的轉變預計將在塑造未來醫療領域聯邦學習市場的成長和技術演進方面發揮核心作用。

最佳化障礙

對技術基礎設施的大量投資是阻礙聯邦學習市場在醫療保健領域發展的主要挑戰之一。在醫療保健環境中部署聯邦學習系統需要大量資金用於先進的運算硬體、安全的網路框架、雲端整合平台和專業的AI軟體解決方案。醫療機構還需要投資高效能伺服器、加密通訊通道、分散式資料管理系統和網路安全技術，以確保安全高效的分散式模型訓練。這些基礎設施需求可能會帶來沉重的財務負擔，尤其對於小規模的醫院、地方醫療機構和預算有限的機構而言。

目錄

第1章摘要整理：全球醫療聯邦學習市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：按地區分類
  • 本研究的前提
  • 市場規模估算
  • 數據三角測量

第3章：全球醫療保健聯邦學習市場概述

  • 產業價值鏈分析
  • 產業展望
    • 人工智慧和隱私保護型機器學習在醫療保健領域的應用概述。
    • 監管環境（HIPAA、GDPR、FDA AI/ML 指南、歐盟 AI 法、資料本地化法案）
  • PESTLE分析
  • 波特五力分析
  • 市場成長及前景
    • 2020-2035年市場收入估算與預測
    • 價格趨勢分析：按組件

第4章：全球醫療保健聯邦學習市場分析

  • 競爭對手儀表板
    • 市場集中度
    • 企業市場占有率分析，2025 年
    • 競爭對手分析與基準測試

第5章：全球醫療保健聯邦學習市場分析

  • 市場動態和趨勢
    • 成長要素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測，2020-2035年
    • 按組件
      • 關鍵見解
        • 軟體平台
        • 基礎架構解決方案
        • 服務
          • 諮詢服務
          • 整合和配置服務
          • 支援和維護服務
          • 培訓服務
    • 部署模式
      • 關鍵見解
        • 基於雲端的
        • 現場
        • 混合
    • 透過學習建築
      • 關鍵見解
        • 水平聯邦學習
        • 垂直聯邦學習
        • 聯邦遷移學習
    • 透過合作模式
      • 關鍵見解
        • 跨孤島聯邦學習
        • 跨裝置聯邦學習
    • 按數據模態
      • 關鍵見解
        • 醫學影像數據
        • 電子健康記錄 (EHR) 數據
        • 基因組數據
        • 穿戴式裝置和遠端監測數據
        • 病理數據
        • 臨床試驗數據
        • 多模態醫療保健數據
    • 用途別
      • 關鍵見解
        • 醫學影像診斷
        • 藥物發現與開發
        • 臨床決策支持
        • 遠端患者監護
        • 精準醫療
        • 團體健康管理
        • 預測分析
        • 臨床研究
        • 疾病風險預測
        • 最佳化醫療保健運營
    • 透過技術整合
      • 關鍵見解
        • 符合差分隱私標準的系統
        • 安全的多方計算系統
        • 區塊鏈整合聯邦學習
        • 利用邊緣人工智慧的聯邦學習
    • 最終用戶
      • 關鍵見解
        • 醫院和醫療保健系統
        • 製藥和生物技術公司
        • 研究和學術機構
        • 診斷檢查室
        • 受託研究機構（CRO）
        • 政府和公共衛生機構
    • 按公司規模
      • 關鍵見解
        • 大公司
        • 中小企業
    • 透過使用環境
      • 關鍵見解
        • 臨床護理環境
        • 研究環境
        • 由多家醫療機構組成的醫療保健網路
    • 按地區
      • 關鍵見解
        • 北美洲
          • 美國
          • 加拿大
          • 墨西哥
        • 歐洲
          • 西歐
            • 英國
            • 德國
            • 法國
            • 義大利
            • 西班牙
            • 其他西歐國家
          • 東歐
            • 波蘭
            • 俄羅斯
            • 其他東歐國家
        • 亞太地區
          • 中國
          • 印度
          • 日本
          • 韓國
          • 澳洲和紐西蘭
          • ASEAN
            • 柬埔寨
            • 印尼
            • 馬來西亞
            • 菲律賓
            • 新加坡
            • 泰國
            • 越南
            • 其他東南亞國協
          • 其他亞太國家
        • 中東和非洲
          • UAE
          • 沙烏地阿拉伯
          • 南非
          • 其他中東和非洲國家
        • 南美洲
          • 阿根廷
          • 巴西
          • 其他南美國家

第6章：北美市場分析

第7章：歐洲市場分析

第8章：亞太市場分析

第9章：中東和非洲市場分析

第10章：南美市場分析

第11章：公司簡介

  • GE HealthCare Technologies, Inc.
  • Google LLC（Alphabet Inc.）
  • Health Catalyst, Inc.
  • IBM Corporation
  • Intel Corporation
  • Medtronic PLC
  • Microsoft Corporation
  • NVIDIA Corporation
  • Owkin
  • Siemens Healthineers AG（Siemens AG）
  • Other Prominent Players

第12章附錄

簡介目錄
Product Code: AA05261791

The global federated learning in healthcare market is witnessing rapid and transformative growth, driven by the increasing demand for secure, privacy-preserving artificial intelligence technologies across the healthcare industry. The market was valued at approximately USD 35.12 million in 2025 and is projected to reach nearly USD 158.3 million by 2035, expanding at a compound annual growth rate (CAGR) of 16.25% during the forecast period from 2026 to 2035. This substantial growth trajectory reflects the rising adoption of decentralized machine learning frameworks that enable healthcare organizations to collaboratively utilize large-scale medical datasets without directly exposing sensitive patient information.

One of the primary factors driving market expansion is the growing need for collaborative healthcare artificial intelligence systems that can operate effectively without compromising patient privacy and data security. Traditional centralized data-sharing models often require healthcare organizations to transfer confidential patient records into unified repositories, increasing the risk of data breaches, unauthorized access, and regulatory non-compliance. Federated learning overcomes these challenges by enabling artificial intelligence models to train locally within institutional infrastructures while only exchanging encrypted model updates rather than raw patient data.

Noteworthy Market Developments

The competitive landscape of the federated learning in healthcare market is characterized by the strong presence of several major technology and healthcare organizations that currently dominate the commercial medical artificial intelligence space. These companies maintain leadership positions through extensive investments in decentralized computing infrastructure, advanced machine learning technologies, secure healthcare analytics platforms, and strategic partnerships with hospitals, pharmaceutical firms, and research institutions.

NVIDIA has emerged as one of the most dominant players in the global healthcare federated learning ecosystem due to its unparalleled computational hardware infrastructure and highly advanced proprietary collaborative artificial intelligence software frameworks. Owkin has secured a significant position within the federated learning in healthcare market through extensive partnerships with major pharmaceutical corporations, biotechnology firms, and clinical research organizations.

Siemens Healthineers maintains substantial influence in the healthcare federated learning market through its extensive control of global diagnostic imaging networks and advanced medical technology ecosystems.GE HealthCare continues to expand its role within the decentralized healthcare intelligence sector by leveraging its vast global network of hospital hardware installations and healthcare technology platforms.

FedML has captured considerable market value by offering highly specialized decentralized machine learning tools specifically designed to protect sensitive healthcare parameters and optimize federated training environments. These leading organizations justify their dominant market positions by actively establishing foundational interoperability standards and decentralized artificial intelligence frameworks that are now widely utilized across the healthcare industry.

Core Growth Drivers

Consumer groups and healthcare stakeholders within the emerging decentralized collaborative diagnostic industry are increasingly demanding immediate and highly reliable privacy-focused solutions for medical data management. As healthcare systems continue to digitize patient records, diagnostic imaging, genomic information, and clinical research datasets, concerns regarding unauthorized access, data misuse, and cybersecurity threats have intensified significantly. Patients are becoming more aware of the risks associated with centralized healthcare databases, particularly as large-scale healthcare data breaches continue to expose sensitive medical information worldwide. This growing awareness has accelerated demand for federated learning technologies that prioritize decentralized data processing and enhanced patient confidentiality while still enabling advanced artificial intelligence-driven healthcare innovation.

Emerging Opportunity Trends

Increasingly strict data localization regulations across multiple countries and healthcare jurisdictions are compelling clinics, hospitals, and medical research organizations to adopt fully decentralized artificial intelligence training paradigms. Governments and regulatory authorities worldwide continue implementing stronger restrictions on cross-border healthcare data transfers to protect patient privacy and national data sovereignty. These evolving regulatory frameworks make centralized healthcare data aggregation increasingly difficult and costly for multinational healthcare organizations. Consequently, federated learning has emerged as a highly attractive alternative, enabling institutions to comply with regional data localization requirements while still participating in global collaborative artificial intelligence initiatives. This shift toward decentralized healthcare analytics is expected to play a central role in shaping the future growth and technological evolution of the federated learning in healthcare market.

Barriers to Optimization

The requirement for substantial financial investment in technological infrastructure represents one of the major challenges that may restrain the growth of federated learning in healthcare market. Implementing federated learning systems within healthcare environments demands extensive spending on advanced computational hardware, secure networking frameworks, cloud integration platforms, and specialized artificial intelligence software solutions. Healthcare organizations must also invest in high-performance servers, encrypted communication channels, distributed data management systems, and cybersecurity technologies to ensure secure and efficient decentralized model training. These infrastructure requirements can create significant financial pressure, particularly for smaller hospitals, regional healthcare providers, and institutions operating within limited budget environments.

Detailed Market Segmentation

By application, the drug discovery and development segment captured the largest share of the federated learning in healthcare market, reflecting the increasing reliance of pharmaceutical and biotechnology companies on decentralized artificial intelligence technologies. This segment emerged as the leading revenue contributor due to the growing need for secure collaborative research environments capable of accelerating complex therapeutic development processes while maintaining strict protection of proprietary scientific data.

By component, specialized software platforms accounted for the dominant share of the federated learning in healthcare market, driven by the growing demand for advanced artificial intelligence coordination systems and secure distributed data management capabilities. These software solutions serve as the operational foundation of federated learning environments, enabling healthcare organizations to efficiently manage decentralized model training, secure communication protocols, and collaborative analytical workflows across multiple institutions.

By data modality, medical imaging files have emerged as the most widely utilized analytical format within the healthcare federated learning ecosystem. These visual datasets play a critical role in the development and deployment of advanced artificial intelligence systems, particularly in areas involving disease diagnosis, clinical imaging interpretation, and predictive healthcare analytics. Medical imaging assets such as magnetic resonance imaging scans, computed tomography images, X-rays, and ultrasound records dominate federated learning implementations due to their high clinical value and their suitability for computer vision applications.

  • Based on the collaboration model, cross-silo federated architectures have emerged as the dominant approach in federated learning healthcare market deployments. These architectures primarily operate through coordinated collaborations among hospitals, healthcare networks, research institutions, and diagnostic laboratories, enabling multiple organizations to jointly train artificial intelligence models without directly sharing sensitive patient data. The growing preference for cross-silo systems is largely driven by the healthcare sector's strong emphasis on privacy protection, regulatory compliance, and secure institutional collaboration.

Segment Breakdown

By Component

  • Software Platforms
  • Infrastructure Solutions
  • Services
  • Consulting Services
  • Integration & Deployment Services
  • Support & Maintenance Services
  • Training Services

By Deployment Mode

  • Cloud-based
  • On-premises
  • Hybrid

By Learning Architecture

  • Horizontal Federated Learning
  • Vertical Federated Learning
  • Federated Transfer Learning

By Collaboration Model

  • Cross-silo Federated Learning
  • Cross-device Federated Learning

By Data Modality

  • Medical Imaging Data
  • Electronic Health Records (EHR) Data
  • Genomic Data
  • Wearable & Remote Monitoring Data
  • Pathology Data
  • Clinical Trial Data
  • Multi-modal Healthcare Data

By Application

  • Medical Imaging & Diagnostics
  • Drug Discovery & Development
  • Clinical Decision Support
  • Remote Patient Monitoring
  • Precision Medicine
  • Population Health Management
  • Predictive Analytics
  • Clinical Research
  • Disease Risk Prediction
  • Healthcare Operations Optimization

By Technology Integration

  • Differential Privacy-enabled Systems
  • Secure Multi-party Computation-enabled Systems
  • Blockchain-integrated Federated Learning
  • Edge AI-enabled Federated Learning

By End User

  • Hospitals & Health Systems
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutions
  • Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Government & Public Health Agencies

By Enterprise Size

  • Large Enterprises
  • Small & Medium-sized Enterprises (SMEs)

By Use Environment

  • Clinical Care Environments
  • Research Environments
  • Multi-institutional Healthcare Networks

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America emerged as the dominant force in the global market, accounting for an impressive thirty-five percent of the overall market share. Healthcare investment, artificial intelligence infrastructure, and advanced digital healthcare ecosystems have all contributed to the region's leadership position.
  • The United States has played a particularly influential role in driving market expansion through proactive regulatory encouragement and policy support for privacy-preserving machine learning innovations. Regulatory authorities have increasingly promoted the development of secure artificial intelligence frameworks that allow healthcare organizations to exchange insights without directly exposing sensitive patient data.

Leading Market Participants

  • GE HealthCare Technologies, Inc.
  • Google LLC (Alphabet Inc.)
  • IBM Corporation
  • Microsoft Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Medtronic PLC
  • NVIDIA Corporation
  • Intel Corporation
  • Health Catalyst, Inc.
  • Owkin
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Federated Learning in Healthcare Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Federated Learning in Healthcare Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Hardware & Edge Compute Infrastructure Providers (GPUs, Servers, Edge Devices)
    • 3.1.2. Cloud & Hybrid Infrastructure Providers
    • 3.1.3. Federated Learning Platform & Framework Developers
    • 3.1.4. Privacy-Preserving Technology Providers (Differential Privacy, SMPC, Blockchain)
    • 3.1.5. Integration, Orchestration & Implementation Service Providers
    • 3.1.6. Healthcare Networks (Hospitals, Pharma, CROs, Research Institutions)
    • 3.1.7. End Users (Clinicians, Researchers, Drug Developers, Public Health Agencies)
  • 3.2. Industry Outlook
    • 3.2.1. Overview of AI in Healthcare & Privacy-Preserving Machine Learning
    • 3.2.2. Regulatory Landscape (HIPAA, GDPR, FDA AI/ML Guidance, EU AI Act, Data Localization Laws)
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Component

Chapter 4. Global Federated Learning in Healthcare Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Federated Learning in Healthcare Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Component
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Software Platforms
        • 5.2.1.1.2. Infrastructure Solutions
        • 5.2.1.1.3. Services
          • 5.2.1.1.3.1. Consulting Services
          • 5.2.1.1.3.2. Integration & Deployment Services
          • 5.2.1.1.3.3. Support & Maintenance Services
          • 5.2.1.1.3.4. Training Services
    • 5.2.2. By Deployment Mode
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Cloud-based
        • 5.2.2.1.2. On-premises
        • 5.2.2.1.3. Hybrid
    • 5.2.3. By Learning Architecture
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Horizontal Federated Learning
        • 5.2.3.1.2. Vertical Federated Learning
        • 5.2.3.1.3. Federated Transfer Learning
    • 5.2.4. By Collaboration Model
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Cross-silo Federated Learning
        • 5.2.4.1.2. Cross-device Federated Learning
    • 5.2.5. By Data Modality
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Medical Imaging Data
        • 5.2.5.1.2. Electronic Health Records (EHR) Data
        • 5.2.5.1.3. Genomic Data
        • 5.2.5.1.4. Wearable & Remote Monitoring Data
        • 5.2.5.1.5. Pathology Data
        • 5.2.5.1.6. Clinical Trial Data
        • 5.2.5.1.7. Multi-modal Healthcare Data
    • 5.2.6. By Application
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. Medical Imaging & Diagnostics
        • 5.2.6.1.2. Drug Discovery & Development
        • 5.2.6.1.3. Clinical Decision Support
        • 5.2.6.1.4. Remote Patient Monitoring
        • 5.2.6.1.5. Precision Medicine
        • 5.2.6.1.6. Population Health Management
        • 5.2.6.1.7. Predictive Analytics
        • 5.2.6.1.8. Clinical Research
        • 5.2.6.1.9. Disease Risk Prediction
        • 5.2.6.1.10. Healthcare Operations Optimization
    • 5.2.7. By Technology Integration
      • 5.2.7.1. Key Insights
        • 5.2.7.1.1. Differential Privacy-enabled Systems
        • 5.2.7.1.2. Secure Multi-party Computation-enabled Systems
        • 5.2.7.1.3. Blockchain-integrated Federated Learning
        • 5.2.7.1.4. Edge AI-enabled Federated Learning
    • 5.2.8. By End User
      • 5.2.8.1. Key Insights
        • 5.2.8.1.1. Hospitals & Health Systems
        • 5.2.8.1.2. Pharmaceutical & Biotechnology Companies
        • 5.2.8.1.3. Research & Academic Institutions
        • 5.2.8.1.4. Diagnostic Laboratories
        • 5.2.8.1.5. Contract Research Organizations (CROs)
        • 5.2.8.1.6. Government & Public Health Agencies
    • 5.2.9. By Enterprise Size
      • 5.2.9.1. Key Insights
        • 5.2.9.1.1. Large Enterprises
        • 5.2.9.1.2. Small & Medium-sized Enterprises (SMEs)
    • 5.2.10. By Use Environment
      • 5.2.10.1. Key Insights
        • 5.2.10.1.1. Clinical Care Environments
        • 5.2.10.1.2. Research Environments
        • 5.2.10.1.3. Multi-institutional Healthcare Networks
    • 5.2.11. By Region
      • 5.2.11.1. Key Insights
        • 5.2.11.1.1. North America
          • 5.2.11.1.1.1. The U.S.
          • 5.2.11.1.1.2. Canada
          • 5.2.11.1.1.3. Mexico
        • 5.2.11.1.2. Europe
          • 5.2.11.1.2.1. Western Europe
            • 5.2.11.1.2.1.1. The UK
            • 5.2.11.1.2.1.2. Germany
            • 5.2.11.1.2.1.3. France
            • 5.2.11.1.2.1.4. Italy
            • 5.2.11.1.2.1.5. Spain
            • 5.2.11.1.2.1.6. Rest of Western Europe
          • 5.2.11.1.2.2. Eastern Europe
            • 5.2.11.1.2.2.1. Poland
            • 5.2.11.1.2.2.2. Russia
            • 5.2.11.1.2.2.3. Rest of Eastern Europe
        • 5.2.11.1.3. Asia Pacific
          • 5.2.11.1.3.1. China
          • 5.2.11.1.3.2. India
          • 5.2.11.1.3.3. Japan
          • 5.2.11.1.3.4. South Korea
          • 5.2.11.1.3.5. Australia & New Zealand
          • 5.2.11.1.3.6. ASEAN
            • 5.2.11.1.3.6.1. Cambodia
            • 5.2.11.1.3.6.2. Indonesia
            • 5.2.11.1.3.6.3. Malaysia
            • 5.2.11.1.3.6.4. Philippines
            • 5.2.11.1.3.6.5. Singapore
            • 5.2.11.1.3.6.6. Thailand
            • 5.2.11.1.3.6.7. Vietnam
            • 5.2.11.1.3.6.8. Rest of ASEAN
          • 5.2.11.1.3.7. Rest of Asia Pacific
        • 5.2.11.1.4. Middle East & Africa
          • 5.2.11.1.4.1. UAE
          • 5.2.11.1.4.2. Saudi Arabia
          • 5.2.11.1.4.3. South Africa
          • 5.2.11.1.4.4. Rest of MEA
        • 5.2.11.1.5. South America
          • 5.2.11.1.5.1. Argentina
          • 5.2.11.1.5.2. Brazil
          • 5.2.11.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Component
      • 6.2.1.2. By Deployment Mode
      • 6.2.1.3. By Learning Architecture
      • 6.2.1.4. By Collaboration Model
      • 6.2.1.5. By Data Modality
      • 6.2.1.6. By Application
      • 6.2.1.7. By Technology Integration
      • 6.2.1.8. By End User
      • 6.2.1.9. By Enterprise Size
      • 6.2.1.10. By Use Environment
      • 6.2.1.11. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Component
      • 7.2.1.2. By Deployment Mode
      • 7.2.1.3. By Learning Architecture
      • 7.2.1.4. By Collaboration Model
      • 7.2.1.5. By Data Modality
      • 7.2.1.6. By Application
      • 7.2.1.7. By Technology Integration
      • 7.2.1.8. By End User
      • 7.2.1.9. By Enterprise Size
      • 7.2.1.10. By Use Environment
      • 7.2.1.11. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Component
      • 8.2.1.2. By Deployment Mode
      • 8.2.1.3. By Learning Architecture
      • 8.2.1.4. By Collaboration Model
      • 8.2.1.5. By Data Modality
      • 8.2.1.6. By Application
      • 8.2.1.7. By Technology Integration
      • 8.2.1.8. By End User
      • 8.2.1.9. By Enterprise Size
      • 8.2.1.10. By Use Environment
      • 8.2.1.11. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Component
      • 9.2.1.2. By Deployment Mode
      • 9.2.1.3. By Learning Architecture
      • 9.2.1.4. By Collaboration Model
      • 9.2.1.5. By Data Modality
      • 9.2.1.6. By Application
      • 9.2.1.7. By Technology Integration
      • 9.2.1.8. By End User
      • 9.2.1.9. By Enterprise Size
      • 9.2.1.10. By Use Environment
      • 9.2.1.11. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Component
      • 10.2.1.2. By Deployment Mode
      • 10.2.1.3. By Learning Architecture
      • 10.2.1.4. By Collaboration Model
      • 10.2.1.5. By Data Modality
      • 10.2.1.6. By Application
      • 10.2.1.7. By Technology Integration
      • 10.2.1.8. By End User
      • 10.2.1.9. By Enterprise Size
      • 10.2.1.10. By Use Environment
      • 10.2.1.11. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. GE HealthCare Technologies, Inc.
  • 11.2. Google LLC (Alphabet Inc.)
  • 11.3. Health Catalyst, Inc.
  • 11.4. IBM Corporation
  • 11.5. Intel Corporation
  • 11.6. Medtronic PLC
  • 11.7. Microsoft Corporation
  • 11.8. NVIDIA Corporation
  • 11.9. Owkin
  • 11.10. Siemens Healthineers AG (Siemens AG)
  • 11.11. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators